LZAGF Stock UPDATES Lonza Group Ltd (LZAGF) 118.2600 09/11/2014

Lonza Group Ltd (LZAGF) 118.2600 $LZAGF

Analyzing the Global Market for Active Pharmaceutical Ingredients - 2014
M2 - Mon Sep 01, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bmprtw/analyzing_the) has announced the addition of the "Analyzing the Global Market for Active Pharmaceutical Ingredients - 2014" report to their offering. This research analyzes the global API industry in its research report Analyzing the Global Market for Active Pharmaceutical Ingredients. The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and upcoming patent expires of blockbuster drugs and the impact of the economic recession on the market. The global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the end of 2014, there is expected to be a major impact on the global API industry. Revenues of the API markets are likely to be affected as generic drugs take up the market. The United States remains one of the biggest players in the market, followed closely by China and India. Synthetic pharmaceuticals also continue to dominate the API industry as biotech APIs move up slowly. Major companies such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the leading players in the global active pharmaceutical ingredient market. Key Topics Covered: 1. Executive Summary 2. Introduction to Active Pharmaceutical Ingredients 3. Global Market for Active Pharmaceutical Ingredients (APIs) 4. Impacts on the Global API Market 5. Market for Active Pharmaceutical Ingredients (APIs) in Asia Pacific 6. Market for Active Pharmaceutical Ingredients (APIs) in Europe 7. Market for Active Pharmaceutical Ingredients (APIs) in North America 8. Major Industry Players - Actavis Plc - Albemarle Corporation - Ampac Fine Chemicals LLC - Aptuit, Inc - Aurobindo Pharma - BASF SE - Biocon Ltd - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Cambrex Corporation - Cipla Ltd - Covidien Plc - Daiichi Fine Chemical Co., Ltd. - Dishman Pharmaceuticals & Chemicals Ltd. - Dr. Reddy's Laboratories Limited - Fabbrica Italiana Sintetici - Hospira Inc - Koninklijke DSM N.V. - Lonza Group AG - Lupin Limited - Matrix Laboratories Limited/Mylan Inc - Novartis AG - Novasep Holding - Pfizer Inc - Ranbaxy Laboratories - Sandoz International GmbH - Sigma-Aldrich Corporation - Sun Pharmaceutical Industries Limited - Teva Pharmaceutical Industries Limited - WuXi AppTec, Inc For more information visit http://www.researchandmarkets.com/research/bm...lyzing_the

Active Pharmaceutical Ingredients Global Market - Forecast to 2020
M2 - Tue Aug 26, 10:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n53c3t/active) has announced the addition of the "Active Pharmaceutical Ingredients Global Market - Forecast to 2020" report to their offering. Active Pharmaceutical Ingredients (API) are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect on diagnosis, prevention or treatment of disease in human and other animals. API's are manufactured by chemical synthesis, fermentation, biotechnological methods or recovered from natural source. Active pharmaceutical ingredient is the important component of every formulated product of pharmaceutical industry and has enormous therapeutic application in the field of cancer, multiple myeloma, respiratory disorders and hormonal imbalance. These ingredients are used in cardiovascular and hematopoietic system, genito-urinary system and as anti-infectives Overall API market is expected to growth at a CAGR of more than 8.0% from 2014 to 2019. The factors such as expiry of patented drugs and shift towards the use of low cost API drugs due to economic recession are driving the growth of active pharmaceutical ingredients market. In addition, the rising adoption of high potent active pharmaceutical ingredients effective in targeted therapy is boosting the global API market growth. While the challenges faced by the market include transparency and increased market fragmentation. Globally North America accounts the largest share in the API market. Asia-Pacific is second largest followed by Europe. Asia is growing at a highest CAGR compared to North America followed by Europe. The key players of Active Pharmaceutical Ingredient market are Sandoz-Lek-Biochemie (Switzerland), GlaxoSmithKline Pharmaceuticals Limited (India), AstraZeneca plc (U.K.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.) and F. Hoffmann-La Roche Ltd. (Switzerland). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Active Pharmaceuticals Ingredients by Synthesis 5. Active Pharmaceuticals Ingredients by Therapeutic Applications 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - Albemarle Corporation - Aurobindo - Boehringer Ingelheim GmbH - Cambrex Corporatio - Dr. Reddy's Lab - Lonza Group - Lupin - Novartis - Ranbaxy Laboratories - Teva Active Pharmaceutical Industries Limited For more information visit http://www.researchandmarkets.com/research/n53c3t/active

Growth Factors (Blood and Tissue) Market 2014 - Global Strategic Business Report
M2 - Thu Aug 14, 2:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bqzzts/growth_factors) has announced the addition of the "Growth Factors (Blood and Tissue) - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following Types: - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) - Tissue Growth Factors. The report profiles 90 companies including many key and niche players such as: - Alseres Pharmaceuticals, Inc. - Amgen, Inc. - Bayer HealthCare Pharmaceuticals, Inc. - Biogen Idec Inc - BioMimetic Therapeutics, Inc. - Biopharm GmbH - Bolder Biotechnology, Inc. - F. Hoffmann-La Roche Ltd - Chugai Pharmaceutical Co. Ltd. - Genentech, Inc. - FibroGen, Inc. - Johnson & Johnson - Janssen Biotech, Inc. - Lonza Group - Merck Serono International S.A. - NsGene A/S - PeproTech, Inc. - Reliance GeneMedix Plc - Sangamo BioSciences, Inc. - Sanofi - Shantha Biotechnics - Scil Proteins GmbH - Wockhardt Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Growth Factors An Overview 3. Research Studies & Clinical Trials 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 90 (including Divisions/Subsidiaries 95) - The United States (42) - Japan ( - Europe (19) - France (1) - Germany ( - The United Kingdom (1) - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (24) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/bq...th_factors

U.S. Antimicrobial Plastics Market - Industry Analysis 2014 - 2020 (Appliances, Personal Care, Packaging, Automotive, Building & Construction, Healthcare)
M2 - Mon Aug 11, 6:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j6gfj6/u_s) has announced the addition of the "U.S. Antimicrobial Plastics Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. Antimicrobial plastics are molded polymers infused with antimicrobials to inhibit the growth of various harmful microorganisms such as fungi and bacteria. Antimicrobial plastics are used in various industries such as healthcare, automotives, building & construction, electronics, packaging and consumer goods. Additionally, they are used in niche applications such as pipes, plastic water storage containers, waste bins and lids. Rising awareness among consumers regarding good health and cleanliness is expected to be one of the primary factors driving the growth of the antimicrobial plastics market. The report on U.S.antimicrobial plastics market report forecasts and analyzes the antimicrobial plastics market on a regional level. The forecast demand on the global level is based on volume (tons) and revenue (USD million) for the period ranging from 2014 to 2020. The study on U.S. antimicrobial plastics market outlines drivers and restraints of the polyester market and their impact on market growth during the mentioned time period. Additionally, the study includes opportunities available for the market on the regional and level and their effect during the said forecast period. All plastics infused with antimicrobials have been classified as antimicrobial plastics under the scope of this study. Personal care includes packaging of personal care products. Packaging of healthcare products has been classified under the packaging segment. Packaging typically includes foods, beverages and pharmaceuticals. In other words, the segment includes all types of packaging, except for personal care products. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Antimicrobial Plastics - Industry Analysis Chapter 4 Antimicrobial Plastics Market - Application Analysis Chapter 5 Company Profiles Companies Mentioned - AkzoNobel N.V. - BASF SE - Bayer AG - Diamond Vogel - E. I. du Pont de Nemours and Company - Ishizuka Glass Co. Ltd. - Lonza Group AG - Momentive Performance Materials Inc. - Sciessent LLC - Sherwin-Williams - Sinanen Zeomic Co Ltd - Teknor Apex - The Dow Chemical Company For more information visit http://www.researchandmarkets.com/research/j6gfj6/u_s

Global Cell Culture Market 2014-2018: Equipment, Reagent, & Application Breakdown
M2 - Thu Jul 17, 9:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c3qkn9/cell_culture) has announced the addition of the "Cell Culture Market by Equipment, by Reagent, by Application - Global Forecast to 2018" report to their offering. The global cell culture market was valued at an estimated $14,772 million in 2013. This market is expected to grow at a CAGR of 10.71% between 2013 and 2018. Cell culture is the most widely used technique for biopharmaceutical production. A large quantity of cell culture media, sera, and reagents is required for biopharmaceutical production. Biopharmaceutical production is the largest application segment for the cell culture market in 2013. Furthermore, according to IMS Health, biopharmaceutical is expected to be one of the fastest growing pharmaceutical segments by 2017. Growth in the biopharmaceutical industry, aided by strong pipelines for antibiotics and vaccine products will drive the growth of the cell culture market. This report segments the global cell culture market into two market segments, namely, the cell culture equipment and cell culture media, sera, and reagents. The cell culture equipment market is further subsegmented into lab equipment, bio-safety cabinets, consumables, storage equipment, and sterilization equipment. The lab equipment segment is further segmented into cell counters, centrifuges, fermentors and bioreactors, and incubators. The storage equipment segment is further segmented into cryogenic storage and refrigerators and freezers. The cell culture media, sera, and reagents market is subsegmented into serum, media, lab reagents, contamination detection kits, cryoprotective agents, and other reagents. The lab reagents segment is further subsegmented into balanced salt solutions, buffers and chemicals, cell dissociation reagents, and supplements and growth factors. The media segment is further subsegmented into basal media, reduced serum media, and serum-free media. Scope of the Report Cell Culture Equipment Market - Cell Culture Lab Equipment - - Cell Counters - - Fermentors & Bioreactors - - Incubators - - Centrifuge - Cell Culture Bio-safety Cabinets - Cell Culture Consumables - Cell Culture Storage Equipment - - Cell Culture Refrigerators & Freezers - - Cell Culture Cryogenic Storage - Cell Culture Sterilization Equipment Cell Culture Media, Sera, & Reagents Market - Serum - - Fetal Bovine Serum & Other Animal Sera - Media - - Basal Media - - Reduced Serum Media - - Serum-free Media - Lab Reagents for Cell Culture - - Cell Culture Supplements & Growth Factors - - Buffers & Chemicals - - Cell Dissociation Reagents - - Balanced Salt Solutions - Contamination Detection Kits - Cryoprotective Agents - Other Reagents Cell Culture Market, By Application - Biopharmaceutical Production - Tissue Culture & Engineering - Vaccine Production - Drug Screening & Development - Gene Therapy - Toxicity Testing - Cancer Research - Other Applications Companies Mentioned - Becton, Dickinson and Company - Corning, Inc. - Eppendorf AG - Lonza Group Ltd. - Merck Kgaa - Promocell GMBH - Sartorius AG - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/c3...ll_culture

International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019
M2 - Thu Jul 10, 6:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3hzhj7/transfection) has announced the addition of the "International Transfection Technology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. Transfection is a technique used to introduce nucleic acids (either DNA or RNA) into cells. This technology helps the cells to regulate gene therapy, mutation of cancer cells and protein metabolism by affecting the nuclear genes. The transfection technology market is driven by factors such as increasing demand for protein production, emerging biopharmaceutical market and rising prevalence of cancer and infectious diseases, globally. The report explains various advancements taking place in this market and analyses the global transfection technology market by types of methods and applications. The method segment of the market is classified as reagent-based method, instrument-based method and virus-based method. The reagent-based method is further segmented as lipid mediated transfection (Lipofection), calcium phosphate, catonic polymers, DEAE-dextran, activated dendrimers and magnetic beads. Likewise, instrument-based method includes electroporation, biolistic technology, microinjection and laserfection.The transfection technology market has also been segmented on the basis of its application in biomedical research, therapeutic delivery (biotherapeutics and electro-chemotherapy and electro-immunotherapy) and protein production. Furthermore, the biomedical research segment includes transgenic models, cancer research, gene and protein expression studies and cell-based microarrays for drug discovery and development. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Transfection Technology Market, by Methods Chapter 5 Global Transfection Technology Market, By Application Chapter 6 Global Transfection Technology Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Bio-Rad Laboratories, Inc. - Harvard Bioscience, Inc. - Life Technologies Corporation - Lonza Group Ltd. - Merck KGaA - Mirus Bio LLC - Polyplus-transfection S.A. - Promega Corporation - QIAGEN - Roche Holding AG - Sigma-Aldrich Corporation - SignaGen Laboratories - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/3h...ansfection

Global Dietary Fiber (Conventional/Novel & Soluble/Insoluble) Market - Forecasts up to 2019
PR Newswire Europe - Wed Jul 02, 1:20PM CDT
DUBLIN, July 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3cmf38/dietary_fiber [http://www.researchandmarkets.com/research/3cmf38/dietary_fiber]) has announced the addition of the "Dietary Fiber Market by Product Type and Application - Global Trends & Forecasts up to 2019" [http://www.researchandmarkets.com/research/3cmf38/dietary_fiber] report to their offering.

Production of Niacin (B3) in China
M2 - Tue Apr 01, 6:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mswqbl/production_of) has announced the addition of the "Production of Niacin in China" report to their offering. Niacin (also known as vitamin B3) includes nicotinic acid and nicotinamide, both of which play the same physiological role. In China, the content of nicotinamide in vitamin B3 accounts for 90%. Producers mainly produce nicotinamide, which is in great demand in the fast-growing feed industry. The production of niacin in China started in the 1960s with small output. After the 20th Century, increase in supply of raw materials and breakthrough in technology promoted the capacity of the product. In 2013, its output is estimated at 21,500 tonnes, making it rank in the top five vitamins. In recent years the capacity of niacin has witnessed stable expansion which is evident in 2012-2013. However, this has led to overcapacity and decline in price. Since 2010, the price of niacin has shown a general downtrend. Drop in prices of raw material also play a role in this. The raw materials, including 3-picoline and 3-cyanopyridine, both experienced large capacity expansion, pulling down their prices. Most niacin producers in China adopt 3-picoline, whose capacity has risen from 20,000t/a in 2008 to 50,200t/a in 2013. Key Topics Covered: 1 Production of niacin 1.1 Production, 2008-2013 1.2 Producer, 2011-2013 1.3 Price, 2010-Nov. 2013 2 Raw materials of niacin 2.1 3-Picoline 2.2 3-Cyanopyridine Companies Mentioned - Brother Enterprises Holding Co., Ltd. - Lonza Group Ltd. - Mianyang Vanetta Pharmaceutical Technology Co., Ltd. - Nanjing Redsun Co., Ltd. - Nantong Acetic Acid Chemical Co., Ltd. - Shandong Luba Chemical Co., Ltd. - Tangshan Chenhong Industrial Co., Ltd. - Vertellus Chemical (Nantong) Co., Ltd. - Zhejiang Lanbo Biotechnology Co., Ltd. For more information visit http://www.researchandmarkets.com/research/ms...duction_of

Global Healthcare BPO Market 2013-2018 - Payer, Provider & Pharmaceutical Trends & Forecasts
M2 - Tue Apr 01, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hnnrlm/healthcare_bpo) has announced the addition of the "Global Healthcare BPO Market 2013-2018 - Payer, Provider & Pharmaceutical Trends & Forecasts" report to their offering. The global healthcare BPO market is dominated by the U.S. A very large percentage of the healthcare BPO requirement arises out of the U.S. Europe is quickly emerging as another important source segment in this market. The U.S. and India are the two largest destination geographies. Philippines and Eastern Europe are two of the fastest growing destination segments in this market. The payer market is segmented into claims processing, member services, HR services, and finance and accounts segments. Claims processing is an important service segment in the payer outsourcing market. It is further sub-divided into claims indexing, claims investigation, claims adjudication, claims repricing, claims settlement, litigation management, and information management. The provider market is segmented into medical billing, medical coding, medical transcription, and finance and account segments. The pharmaceutical outsourcing market is segmented into contract research organizations (CRO), contract manufacturing organizations (CMO), and business support services. Each service segment in the pharmaceutical outsourcing market is divided into further sub-segments. The CRO service segment is sub-divided into drug discovery, pre-clinical, clinical phases I, II, III and IV, clinical data management and biostatistics, medical writing, regulatory services, and non-clinical functions. The CMO service segment is sub-divided into API manufacturing, and formulation and packaging. The non-clinical service segment is sub-divided into supply chain management and logistics, sales and marketing, and non-clinical functions. The report also highlights the marketing KPO function in the sales and marketing outsourcing segment. Scope Healthcare BPO Market Payer - Claims Processing - HR Services - Finance & Accounts Provider - Medical Billing & Coding Pharmaceutical - Clinical Trial - Contract Manufacturing - Non-Clinical Services Key Topics Covered: - Introduction - Executive Summary - Market Overview - Healthcare Payer Outsourcing Market - Healthcare Provider Outsourcing Market - Pharmaceutical Outsourcing Market - Geographical Analysis - Competitive Landscape - Company Profiles - Accenture Plc - Accretive Health, Inc. - Anthelio Healthcare Solutions, Inc. - Boehringer Ingelheim Gmbh - Catalent Pharma Solutions, Inc. - Charles River Laboratories International, Inc. - Cognizant Technology Solutions Corporation - Covance, Inc. - Gebbs Healthcare Solutions, Inc. - Genpact Limited - Ibm Corporation - Icon Plc - Igate Patni - Infosys Bpo Limited - Inventiv Health Inc - Lonza Group Ltd. - Medusind Solutions Inc - Mphasis Limited - Omega Healthcare Management Services Pvt Ltd - Parexel International Corporation - Patheon Inc - Pharmaceutical Product Development, Inc. - Piramal Enterprises Limited - Quintiles Transnational Holdings, Inc. - Tata Consultancy Services Ltd - Tech Mahindra - Teleradiology Solutions Pvt Ltd. - Wns (Holdings) Limited - Xerox Corporation Visit http://www.researchandmarkets.com/research/hn...thcare_bpo

The Global Dietary Fiber Market in Terms of Volume is Projected to Grow at a CAGR of 10.4% from 2014 to 2019
M2 - Wed Mar 26, 7:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7743h2/dietary_fiber) has announced the addition of the "Dietary Fiber Market by Product Type and Application - Global Trends & Forecasts up to 2019" report to their offering. This report estimates the market size of the dietary fiber market in terms of both value and volume. Functional foods, bakery & confectionery, dairy, beverage, meat products, and pharmaceuticals are the end-user applications for dietary fiber. With the increasing penchant for health benefits, the market is likely to witness a robust growth in the years ahead. The dietary fiber market volume is estimated to reach 465,128.3 metric tons by 2019, growing at a CAGR of 10.4% from 2014 to 2019. The end-use sectors are exhibiting buoyant growth driven by the global aging population and customer preferences towards dietary fibers. The dietary fiber market was dominated by the supplements segment both in value and volume terms. Functional foods were the most dominant sector in food applications for dietary fibers. Major players like Cargill Inc. (U.S.), E.I. DuPont de Nemours (U.S.), Lonza Group (Switzerland), Roquette Freres (France) are scaling their business by bringing in new products and pursuing mergers and acquisitions in developing markets. Top eight players in the dietary fiber industry held a market share of around 65.0% depicting the participation of other small players in the industry. Although dominated by conventional fibers, the novel fibers segment is projected to drive the growth 2014 to 2019. The penetration of conventional fibers is high in the developing countries and these are expected to witness a sluggish growth in the years ahead due to the rapid growth and acceptance of novel fibers. For more information visit http://www.researchandmarkets.com/research/77...tary_fiber About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016
M2 - Thu Mar 13, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bgc2v8/global) has announced the addition of the "Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016" report to their offering. One of the main trends witnessed in the Global Electrophoresis Equipment market is the increase in mergers and acquisitions. The Global Electrophoresis Equipment market was marked by a number of mergers and acquisitions by leading vendors. These mergers and acquisitions are done with an intention to increase the vendors' global presence, prevent the loss of patents, and achieve economies of scale. For instance, in 2011, Danaher Corp. acquired Beckman Coulter, which has a wide product portfolio of laboratory instruments. In addition, Agilent Technologies Inc. acquired Dako A/S in July 2012 and Accelicon Technologies Inc. in February 2012. According to the report, one of the main factors driving the market is the Increase in Technological Innovations. The latest technological advancements in various healthcare operations and the sophisticated approaches used in them have increased the demand for electrophoresis equipment. New technologies have helped improve the accuracy, cost, sensitivity, and analysis speed of electrophoresis equipment. Further, the report states that one of the main challenges is the intense competition among vendors. The Global Electrophoresis Equipment market is highly fragmented because of the presence of a large number of vendors. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned: - Agilent Technologies Inc. - Bio-Rad Laboratories Inc. - C.B.S Scientific Inc. - GE Healthcare Ltd. - Helena Laboratories Corp. - Hoefer Inc. - Life Technologies Corp. - Lonza Group AG - PerkinElmer Inc. - SERVA Electrophoresis GmbH - Sebia S.A. - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/bgc2v8/global

Global Life Sciences BPO Market Market Forecasts & Opportunities, 2019
M2 - Mon Mar 10, 9:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gh67xx/life_sciences_bpo) has announced the addition of the "Global Life Sciences BPO Market Market Forecasts & Opportunities, 2019" report to their offering. The life sciences BPO market comprises services offered by Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) to the biotech pharmaceutical companies. A rise in demand for low cost drugs, patent expirations and uncertain economic conditions have compelled the pharmaceutical players to take support of various outsourcing services. This support has facilitated pharma players to streamline their value chain and focus more on its core strategies. Pharmaceutical companies are now forming long term partnership with the CROs and CMOs to share the costs involved in drug discovery to post marketing approvals. Moreover, they are also leveraging CROs and CMOs expertise such as use of novel technologies, trained staff and previous experiences for effective outcomes. The research report on life sciences BPO provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of this market. The report discusses the market of life sciences BPO on the basis of different CRO and CMO services. The CRO services comprises clinical data management, monitoring, medical writing, regulatory services, pharmacovigilance, bio-statistics, drug discovery and pre-clinical tests. The CMO services include API manufacturing, Finished Dosage Formulation development and manufacturing and Packaging. The global life sciences BPO market has been segmented based on all the above- mentioned parameters and market size estimates and forecasts for the period of 2011 to 2019 have been provided for each of the segments, in terms of USD million, considering 2012 as the base year for calculations and 2011 representing as the historical year. The market overview section gives a detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global life sciences BPO market.The section also covers opportunities, market attractiveness analysis and Porter's Five Forces analysis for the market participants. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Life Sciences BPO Market Dynamics Chapter 4 Global Life Sciences BPO Market, by Segments Chapter 5 Global Life Sciences BPO Market, by Geography Chapter 6 Global Life Sciences BPO Market Share Analysis Chapter 7 Recommendations Chapter 8 Company Profiles - Accenture, Plc - Boehringer Ingelheim GmbH - Catalent Pharma Solutions, Inc. - Charles River Laboratories International, Inc. (CRL) - Cognizant Technology Solutions - Covance, Inc. - DSM - Fareva - ICON, Plc - Infosys - International Business Machines Corporation - Lonza Group - Pharmaceutical Product Development, Inc. (PPD, Inc.) - Parexel International Corporation - Patheon, Inc. - Piramal Healthcare - PRA International, Inc. - Quintiles Transnational Corporation - Wipro Limited For more information visit http://www.researchandmarkets.com/research/gh...iences_bpo

2014 Mesenchymal Stem Cells Global Strategic Business Report - Widespread Commercialization of 'Off-the-Shelf' MSCs to Become a Reality
M2 - Mon Mar 10, 4:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hz38cb/mesenchymal_stem) has announced the addition of the "Mesenchymal Stem Cells - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Mesenchymal Stem Cells (MSCs) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. MARKET DRIVERS, TRENDS & ISSUES - Ageing Demographics to Drive Demand for Mesenchymal Stem Cell Therapies - Adult Stem Cells Therapies on Growth Trajectory, as Controversies Continue to Haunt Embryonic Stem Cell Research - Adult Stem Cells and Embryonic Stem Cells - A Comparison - MSCs versus Embryonic or Induced Pluripotent Stem Cells - MSC Therapies Immune to Ethical Issues Applicable to Embryonic Stem Cells - MSCs - A Potential Vehicle for 'Targeted Drug Delivery' - Loopholes Associated with In Vivo Properties Constrain Therapeutic Advancements - Major Challenges Confronting Mesenchymal Stem Cell Market 3. STEM CELL MARKET - A MACRO PERSPECTIVE 4. REVIEW OF SELECT MAJOR STEM CELL VARIANTS - Adult Stem Cells - A Low Risk Investment - Adult Stem Cells Garner More Investments for Research - Low Versatility - A Major Limiting Factor of Adult Stem Cells - Hematopoietic Stem Cells - Enjoying Enduring Success - Restraining Factors - Induced Pluripotent Stem Cells - An Alternative to ESCs - A Peek into the Discovery of iPS - Drug Development - A Major Application for iPS - Use of iPS for Regenerative Medicine - Establishing iPS Cell Banks - Intractable and Congenital Disease Treatments - Embryonic Stem Cells to Transfigure Medicine - Ethical Issues and Technical Hurdles Bog Down hESC Research - Lack of Safety and Efficacy Data - A Key Concern 5. MESENCHYMAL STEM CELL RESEARCH BY APPLICATION 6. PRODUCT OVERVIEW 7. PRODUCT INNOVATIONS/LAUNCHES 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. REST OF WORLD IV. COMPETITIVE LANDSCAPE Companies Profiled The report profiles 51 companies including many key and niche players such as: - Aastrom Biosciences - Cell Applications - Celprogen - Cyagen Biosciences - EMD Millipore - Genlantis - Life Technologies - Lonza Group - Mesoblast - Neuromics - Osiris Therapeutics - Orthofix International - PromoCell - R&D Systems - ScienCell Research Laboratories - Stemcell Technologies - Stemedica Cell Technologies - StemGenesis - Trevigen - Vitro Biopharma For more information visit http://www.researchandmarkets.com/research/hz...hymal_stem About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Water Treatment Chemicals Market By Type & Application - Global Trends & Forecasts to 2018
M2 - Mon Mar 10, 3:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lbf25h/water_treatment) has announced the addition of the "Water Treatment Chemicals Market By Type & Application - Global Trends & Forecasts to 2018" report to their offering. Water treatment chemicals are primarily used for removing impurities from drinking as well as industrial water and wastewater. With the increasing scarcity of water resources globally, recycling and reuse of water has become very important. Water treatment chemicals are used effectively to remove harmful substances from water. Key chemicals that are used in the water treatment include corrosion inhibitors, scale inhibitors, coagulants & flocculants, biocides & disinfectants, chelating agents, anti-foaming agents, ph adjusters & stabilizers, and others. Coagulants & flocculants are the most commonly used water treatment chemicals. However, scale and corrosion inhibitors together represent the significant market share in terms of value. Biocides and disinfectants also represent more than 10% of the value market, and are expected to grow at a decent pace. However, increasing regulations against the use of chemicals in water treatment is one of the key restraints in the industry. Water treatment chemicals are used in industries such as power generation, food & beverage, chemical processing, pulp & paper, oil & gas, metal & mining, and others. Power generation is the important industrial application area for water treatment chemicals. Municipal water treatment represents around 35% of the total consumption of water treatment chemicals globally. Geographically, Asia-Pacific is the key market for water treatment chemicals. It represents more than 35% of the market in terms of consumption. Rising demand for clean water in China and India is driving the Asia-Pacific as well as the global market for water treatment chemicals. China is the largest consumer for water treatment chemicals in the world. Key Topics Covered: Introduction Executive Summary Premium Insights Market Overview Water Treatment Chemicals Market, By Types Water Treatment Chemicals Market, By Applications Water Treatment Chemicals Market, By Geography Competitive Landscape Company Profiles List of Tables List of Figures Companies Mentioned - Air Products & Chemicals Inc. - Akzonobel N.V. - Ashland Inc. - Basf Se - Buckman Laboratories International Inc. - Bwa Water Additives Uk Limited - Carus Corporation - Chemtreat Inc. - Cortec Corporation - Ecolab Inc.(Nalco Company) - Feralco Ab - Ge Water & Process Technologies - Kemira Oyj - Kurita Water Industries Ltd. - Lonza Group Ltd. - Nippon Rensui Co. - Plymouth Technology Inc. - Snf Group - The Dow Chemical Company - Thermax Ltd. - Veolia Water Solutions & Technologies - Wujin Fine Chemical Factory Co. Ltd. For more information visit http://www.researchandmarkets.com/research/lb..._treatment About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Global Water and Wastewater Treatment Chemicals Market Forecast and Opportunities, 2018
M2 - Fri Mar 07, 8:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/h9xcxt/global_water_and) has announced the addition of the "Global Water and Wastewater Treatment Chemicals Market Forecast and Opportunities, 2018" report to their offering. The global water and wastewater treatment chemicals market is projected to grow at a CAGR of around 4.5% during 2013-18 as a result of growing usage of water in end user industries and stringent water treatment regulations across the globe. Shale gas and oil exploration, geothermal energy as well as renewable sources of energy consume considerable amount of water for their operations which is further driving the market. Growing desalination trends in water scarce regions, especially the Middle East and Asia-Pacific, has promoted the growth of membrane chemicals like antiscalants, antifoulants and other cleaning chemicals. Nanotechnology based chemicals and biodegradable chemicals have increased the usage of high performance water treatment chemicals, especially in developed markets of North America and Europe. Wastewater from industries such as power, paper and pulp, chemical processing, metal and mining is one of the major contributors to the rising water pollution, globally. As a result, new regulations for maximum limits of pollutants are being passed, globally, depending on the industry and type of pollutant. Consequently, the demand for chemicals utilized in the industrial and municipal wastewater applications is expected to witness long-term increase over the next 10-15 years. In emerging markets, improvements of health and sanitation standards are the major drivers for the growth in water and wastewater treatment chemicals market. Globally, about 2.5 billion people, largely from Asia and Africa, have inadequate water supplies, according to World Bank estimates, which is gradually being addressed with the establishment of water treatment facilities. Key Topics Covered: 1. Analyst View 2. Global Water Market Overview 3. Global Water and Wastewater Treatment Chemicals 4. Global Water and Wastewater Treatment Chemicals Regional Analysis 5. Segmental Analysis 6. Market Drivers & Restraints 7. Policy and Regulatory Landscape 8. Market Trends & Developments 9. Price Point Analysis 10. Competitive Landscape 11. Strategic Recommendations 12. Research Methodology Companies Mentioned - AkzoNobel N.V - Ashland Inc. - BASF SE - BWA Water Additives - Buckman Laboratories - Carus Corporation - ChemTreat Inc. - E. I. du Pont de Nemours and Company - Ecolab, Inc. - GE Water and Process Technologies - Hydrite Chemical Co. - Ion Exchange India Limited - Kemira Oyj - Kurita Water Industries Ltd. - Lonza Group AG - The Dow Chemical Company - Thermax Limited - Veolia Water For more information visit http://www.researchandmarkets.com/research/h9..._water_and

Global Specialty Chemicals Market 2014-2018: Trend of Mergers and Acquisitions Expected to Continue in the High Growth Areas of Latin America and the APAC Region
M2 - Fri Mar 07, 6:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/kqdpg3/global_specialty) has announced the addition of the "Global Specialty Chemicals Market 2014-2018" report to their offering. The analysts forecast the Global Specialty Chemicals market to grow at a CAGR of 5.16 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing demand for specialty chemicals products in the rapidly developing countries of the APAC region. The Global Specialty Chemicals market has also been witnessing the increase in mergers and acquisitions through which key players in the market are increasing their penetration in the emerging economies. However, the increasingly stringent health and environmental regulations could pose a challenge to the growth of this market. Key vendors dominating this space are 3M Company, AkzoNobel NV, Arkema SA, BASF SE, Bayer AG, Clariant AG, Dow Chemical Co., Evonik Industries Inc., Ecolab Inc., E. I. du Pont de Nemours and Co., Henkel AG & Co. KGaA, Koninklijke DSM NV, PPG Industries Inc., Solvay-Rhodia, and Syngenta AG. Other vendors mentioned in the report are Ashland Inc., Avery Dennison Corp., DIC Corp., Eastman Chemical Co., Givaudan SA, Honeywell International Inc., Huntsman Corp., Lonza Group, Lubrizol Corp., Merck KGaA, Momentive Performance Materials Holdings Inc., Monsanto Co., RPM International Inc., Sherwin-Williams Co., Shin-Etsu Chemical Co. Ltd., Toray Industries Inc., Valspar Corp., and Wacker Chemie AG. Commenting on the report, an analyst from the team said: Many SMEs involved in chemical manufacturing are effective in the production of specialty chemicals for niche markets, though they lack in logistics for manufacturing specialty chemicals in bulk. Since the Specialty Chemicals market is highly fragmented, the key players are trying to gain more market share through the mergers and acquisitions of smaller firms. This trend will help the large vendors to grow and improve their networks at a faster pace. Moreover, the mergers and acquisitions strategy will help the bigger players to penetrate the markets in the emerging economies of Latin America and the APAC region. Global chemical manufacturers that have a large geographic presence, diversified product portfolio, and technical expertise for providing VAS are preferred by large industrial consumers. The mergers and acquisitions strategy serves all three main purposes of improving efficiency, diversifying product portfolio, and expanding the vendors' geographic presence. For more information visit http://www.researchandmarkets.com/research/kq..._specialty About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Concise Analysis of the International Food Emulsifiers Market Report
M2 - Tue Feb 25, 4:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/q79fj3/food_emulsifiers) has announced the addition of the "Concise Analysis of the International Food Emulsifiers Market Report" report to their offering. The food emulsifiers market is considered to be one of the fastest growing segments of food additives market due to the growing trend towards reducing fat content in the food products. The emulsifiers market is largely driven by mono-, di-glycerides & derivatives, lecithin, stearoyl lactylates, and other emulsifiers such as polyglycerol esters (PGE), polyglycerol poly-ricinoleate (PGPR). Many other synthetic as well as natural emulsifiers are expected to gain momentum in the near future. However, researches in various fields have opened up new avenues for the application of these ingredients. Convenience foods, beverages, and other food products are now picking up pace. The global food emulsifiers market was $2,108.0 million in 2012 and is expected to reach $2,858.6 million by 2018, growing at a CAGR of 5.2% from 2013 to 2018. The flourishing food & beverage sector across the globe willl drive the market for food emulsifiers. The global food emulsifiers market in 2012 was dominated by mono- and di-glycerides & derivatives in terms of value and in volume. In last few years, research on emulsifiers has progressed moderately and significant technological advances have been made in selection & characterization of specific emulsifiers and substantiation of health claims relating to its consumption. Emulsifiers are widely used across the globe as they improve the texture, product consistency, aid in blending the ingredients well and provide good taste to the product. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Food Emulsifiers Market, By Types 6 Global Food Emulsifiers Market, By Applications 7 Food Emulsifier Market, By Geography 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - AB Nordbakels - Adani Wilmar - Archer Daniels Midland - Beldem - Cargill - EI Dupont De Nemours & Company - Estelle Chemicals - Ingredion - Kerry - Lasenor Emul - Lecico Gmbh - Lonza Group - Masson Group Company Limited - Palsgaard - Riken Vitamin - Royal Dsm - Solvay Chemicals - Stepan Company - Sternchemie For more information visit http://www.researchandmarkets.com/research/q7...mulsifiers

Electrophoresis Equipment and Supplies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Mon Feb 24, 5:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/6lhd89/electrophoresis) has announced the addition of the "Electrophoresis Equipment and Supplies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Electrophoresis is the most frequently utilized separation and analysis technology in pharmaceutical, life science and biotechnology laboratories. It has been a method of choice to physically separate macromolecules such as RNA, nucleic acid fragments and proteins according to their molecular size and electric charge. Molecular profiling applications are expanding recently and are also providing continuous demand for electrophoresis technique. Protein separation and nucleic acid are two major applications of electrophoresis. Electrophoresis equipment market can be broadly segmented as gel electrophoresis equipment and capillary electrophoresis equipment. Genomics application has assisted the growth of gel electrophoresis. In 2012, 53% of the total electrophoresis market was acquired by gel electrophoresis. A paradigm shift from genomics to proteomicshas beenobserved in the marketconsequentlyaiding thegrowth of two-dimensional gel electrophoresis equipment. The applications market for electrophoresis can be segmented as protein diagnostics, hemoglobin analysis and microbial detection. In 2012, hemoglobin analysis captured themajor market share of electrophoresis equipment by applications. Hemoglobin electrophoresis was observed to be the one of the most accurate, precise and frequently used DNA analysis techniques in the market.Capillary electrophoresis equipment has major application in hemoglobin analysis and is considered as one of the most advanced equipment fornucleic acid separation in the market. Key Topics Covered - Introduction - Executive Summary - Market Overview - Global Electrophoresis Equipment and Supplies Market, by Technology, 2013 - 2019 (USD Million) - Global Electrophoresis Equipment and Supplies Market, by Applications, 2013 - 2019 (USD Million) - Global Electrophoresis Equipment and Supplies Market, by Geography, 2013 - 2019 (USD Million) - Competitive Landscape - Recommendations - Company Profiles Companies Mentioned - Agilent Technologies - Bio-Rad Laboratories - Danaher Corporation (Beckman Coulter) - GE Healthcare - Harvard Bioscience - Helena Laboratories - Life Technologies - Lonza Group - Perkin Elmer - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/6l...rophoresis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Global Vitamins Market 2014-2018: Cosmeceutical Industry Expected to Grow at a CAGR of Over 7% during Forecast Period
M2 - Mon Feb 17, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/cp6qhr/global_vitamins) has announced the addition of the "Global Vitamins Market 2014-2018" report to their offering. The analysts forecast the Global Vitamins market to grow at a CAGR of 6.15 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased use in functional food and beverages. The Global Vitamins market has also been witnessing increasing demand from the Cosmeceuticals industry. However, differences in consumer preferences could pose a challenge to the growth of this market. Key vendors dominating this space are Adisseo France S.A.S, Archer Daniels Midland Co., BASF SE, and Royal DSM N.V. Other vendors mentioned in the report are 7 Day Health Corp., ABH Nature's Products Inc., AIE Pharmaceuticals Inc., Aland (Jiangsu) Nutraceutical Co. Ltd., Atlantic Essential Products Inc., Atrium Innovations Inc., Bactolac Pharmaceutical Inc., Bluebonnet Nutrition Corp., CSPC Pharmaceutical Group Ltd., Danisco A/S, Glanbia Nutritionals Deutschland GmbH, Kirkman Group Inc., Lonza Group Ltd., Nattopharma ASA, Nature's Plus, NBTY Inc., North China Pharmaceutical Corp., Nulab Inc., Nutricap Labs, Nutrilite, Nutrilo GmbH, ParkAcre Enterprises Ltd., Pfizer Inc., Pharmavite LLC, Private Label Nutraceuticals LLC, Sanofi SA, Schiff Nutrition International Inc., Thorne Research Inc., Vertellus Specialties Inc., and Zhejiang Hangzhou Xinfu Pharmaceutical Co. Ltd. Commenting on the report, an analyst from the team said: Cosmeceuticals are cosmetics with pharmacological benefits. The Global Vitamins market is witnessing an increasing demand from the Cosmeceutical industry, which is expected to grow at a CAGR of over 7 percent during the forecast period. The demand for vitamins is particularly strong from the Skin Care segment of the Cosmeceutical industry. Some of the vitamins that are commonly used by this segment are vitamin B3, vitamin K, vitamin E, and vitamin A and its derivatives, such as retinol, retinaldehyde, oxoretinoids, and retinyl esters. Also, cosmeceuticals with vitamins are increasingly used as therapeutic adjuncts. According to the report, many drivers are contributing to the growth of the Global Vitamins market, the most important of which is the increased use of vitamins in functional food and beverages. While vitamins are largely consumed as dietary supplements, their usage in functional food and beverages has increased significantly, thereby contributing to the growth of the market. For more information visit http://www.researchandmarkets.com/research/cp...l_vitamins About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Global 3D Flat Panel TV Market 2014-2018: Several Videogame Makers Investing Heavily in Making 3D Video Games
M2 - Thu Feb 13, 6:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/bjrqxw/global_3d_flat) has announced the addition of the "Global 3D Flat Panel TV Market 2014-2018" report to their offering. The analysts forecast the Global 3D Flat Panel TV market to grow at a CAGR of 15.4 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in 3D content broadcasts. The Global 3D Flat Panel TV market has also been witnessing the emergence of 4K resolution technology. However, the health risk associated with 3D technology could pose a challenge to the growth of this market. Key vendors dominating this space are LG Electronics Inc., Samsung Electronics Co. Ltd., and Sony Corp. Other vendors mentioned in the report are Panasonic Corp., Koninklijke Philips N.V., Sharp Corp., and Toshiba Corp. Commenting on the report, an analyst from the team said: The increasing popularity of 3D gaming among consumers is driving the Global 3D Flat Panel TV market. 3D gaming is an immersive experience that provides a real world experience to its users. Several videogame makers such as Sony Computer Entertainment Inc., Nintendo Co. Ltd., Electronic Arts Inc., Capcom Co. Ltd., Take-Two Interactive Software Inc., and Warner Bros. Interactive Entertainment Inc. are investing heavily in making 3D video games. This increasing popularity of 3D games has encouraged the vendors to manufacture and upgrade 3D TVs to support 3D gaming. According to the report, 3D technology is being used in the Entertainment sector such as 3D films, video games, gaming consoles, and 3D TVs. Blockbuster movies like Avatar not only increased the public awareness of 3D media but also increased the popularity of 3D films across the world. For more information visit http://www.researchandmarkets.com/research/bj...al_3d_flat About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.